Atlas Trials

Immune Checkpoints in Predicting Response to Neoadjuvant Therapy in Rectal Cancer

Clinical trial NCT05457075 · COMPLETED

Trial details

NCT number
NCT05457075
Sponsor
Istanbul Training and Research Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Rectal Cancer
Start date
2022-05-01
Primary completion
2022-12-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.